Orbis Biosciences

Read more
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

2008

Est. Annual Revenue
$3.5M
Agree?
Est. Employees
16
Agree?

ORBIS BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Orbis Biosciences's company profile
CEO Avatar

CEO

- -
16
$1.2M
$3.5M
View Profile
1
Orbis Biosciences's Competitor - Otonomy logo
David A Weber's photo - President & CEO of Otonomy

David A Weber

President & CEO

87/100
49
$229.7M
$ < 1M
View Profile
2
Orbis Biosciences's Competitor - Amplicore logo
C James Lin's photo - President & CEO of Amplicore

C James Lin

President & CEO

90/100
9
$6.8M
$ < 1M
View Profile
3
Orbis Biosciences's Competitor - Quark Pharmaceuticals logo
Gal Cohen's photo - Chairman & CEO of Quark Pharmaceuticals

Gal Cohen

Chairman & CEO

82/100
150
$37M
$15M
View Profile
4
Orbis Biosciences's Competitor - Lonza logo
Pierre-Alain Ruffieux's photo - CEO of Lonza

Pierre-Alain Ruffieux

CEO

98/100
17,153
$874M
$5.1B
View Profile
5
Orbis Biosciences's Competitor - Formex logo
Cyrus K. Mirsaidi's photo - President & CEO of Formex

Cyrus K. Mirsaidi

President & CEO

94/100
57
- -
$6.8M
View Profile
6
Orbis Biosciences's Competitor - Catalent logo
John Chiminski's photo - Chairman & CEO of Catalent

John Chiminski

Chairman & CEO

63/100
12,300
$1.5B
$4B
View Profile
7
Orbis Biosciences's Competitor - Florikan logo
CEO Avatar

CEO

- -
34
- -
$3.2M
View Profile
8
Orbis Biosciences's Competitor - Clinical Supplies Management, Inc. logo
Scott Houlton's photo - CEO of Clinical Supplies Management, Inc.

Scott Houlton

CEO

81/100
300
- -
$25M
View Profile
9
Orbis Biosciences's Competitor - Patheon logo
CEO Avatar

CEO

- -
9,100
$625M
$1.7B
View Profile
10
Orbis Biosciences's Competitor - Kemin logo
Christopher E. Nelson's photo - President & CEO of Kemin

Christopher E. Nelson

President & CEO

76/100
2,800
$225M
$710M
View Profile
11
Orbis Biosciences's Competitor - DSM logo
Geraldine Matchett's photo - Co-CEO of DSM

Geraldine Matchett

Co-CEO

78/100
23,127
$3.8B
$10.2B
View Profile
12
Orbis Biosciences's Competitor - Ceutical Labs logo
Courtland Imel's photo - CEO of Ceutical Labs

Courtland Imel

CEO

- -
186
- -
$41.8M
View Profile

Missing a competitor? Contribute!

Otonomy has been one of Orbis Biosciences's top competitors. Otonomy was founded in 2008, and is headquartered in San Diego, California. Otonomy competes in the Pharmaceuticals industry. Otonomy generates $3.2M less revenue vs. Orbis Biosciences.

Amplicore is a top competitor of Orbis Biosciences. Amplicore is a Private company that was founded in Mason, Ohio in 2018. Like Orbis Biosciences, Amplicore also competes in the Pharmaceuticals industry. Amplicore has 7 fewer employees vs. Orbis Biosciences.

Quark Pharmaceuticals is perceived as one of Orbis Biosciences's biggest rivals. Quark Pharmaceuticals was founded in 1994, and its headquarters is in Newark, California. Like Orbis Biosciences, Quark Pharmaceuticals also operates in the Pharmaceuticals field. Quark Pharmaceuticals has 134 more employees than Orbis Biosciences.

Orbis Biosciences Acquisitions

No recent acquisitions found related to Orbis Biosciences

Orbis Biosciences Funding History

Since Orbis Biosciences was founded in 2008, it has participated in 2 rounds of funding. In total Orbis Biosciences has raised $1.2M. Orbis Biosciences' last funding round was on Oct 2016 for a total of $985.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Oct 2016
$985K
-
Equity
May 2009
$250K
-

Since Orbis Biosciences was founded in 2008, it has participated in 2 rounds of funding. In total Orbis Biosciences has raised $1.2M. Orbis Biosciences' last funding round was on Oct 2016 for a total of $985.0K

Orbis Biosciences Investments

No recent investments found related to Orbis Biosciences

Orbis Biosciences News

March 12, 2018Reuters

BRIEF-Dare Bioscience Announces Development And Option Agreement With Orbis Biosciences For Long-Acting Injectable Contraceptive

* DARÉ BIOSCIENCE ANNOUNCES EXCLUSIVE DEVELOPMENT AND OPTION AGREEMENT WITH ORBIS BIOSCIENCES FOR LON... See more »
January 3, 2018The Business Journals: Kansas City

Lenexa biotech lands big licensing deal for pharma manufacturing

Orbis Biosciences Inc., a Lenexa-based pharmaceutical company, landed a big licensing deal for one of... See more »
January 3, 2018ClinicaSpace

Orbis Biosciences Announces Licensing Agreement with Reckitt Benckiser

The technology will enable new products for a leading segment of RB's product portfolio. Detailed fin... See more »

Orbis Biosciences Blogs

March 31, 2020Orbis Biosciences Blog

WHO celebrates nurses and midwives around the world

This year is the International Year of the Nurse and the Midwife. On April 7th, 2020, nurses and midw... See more »
March 14, 2020Orbis Biosciences Blog

Where do germs live?

According to the Mayo Clinic, "germs are everywhere." Flu season or not, germs are around, and they s... See more »
February 11, 2020Orbis Biosciences Blog

How to Overcome Seasonal Depression

Have you felt a significant zap in your energy or mood? You may be SAD - literally. Seasonal Affectiv... See more »
July 1, 2019Orbis Biosciences Blog

Carbon monoxide poisoning can be treated by the FDA's new approved device

The U.S. Food and Drug Administration (FDA) is now allowing the marketing of ClearMate, a new device ... See more »
July 1, 2019Orbis Biosciences Blog

Carbon monoxide poisoning can be treated by the FDA’s new approved device

The U.S. Food and Drug Administration (FDA) is now allowing the marketing of ClearMate, a new device ... See more »
May 14, 2019Orbis Biosciences Blog

Self-destructive mechanism may lead to new tuberculosis drugs

While the number of tuberculosis cases have steadily decreased since 1993, TB is still one of the wor... See more »
May 10, 2019Orbis Biosciences Blog

Where the Kansas City Animal Health Corridor and Technology Galaxy Meet

"Headquartered in Kansas City, Kansas, Aratana brings decades of human health and biotechnology exper... See more »

Orbis Biosciences Press Releases

March 2, 2015BUSINESS WIRE

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2015 - 11 Drug Profiles from 4 Companies

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3cdk86/naso... See more »
February 27, 2015BUSINESS WIRE

Acute Sensorineural Hearing Loss Therapeutics Pipeline Review 2015 - 6 Companies & 8 Drug profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4qb5jp/acut... See more »

Social Media

Orbis Biosciences Headquarters

8006 Reeder Street

Lenexa, Kansas66214

913-544-1199

Driving Directions »

Trending Companies

Orbis Biosciences Summary

ABOUT

Overview

Orbis Biosciences develops and provides release delivery systems for pharmaceutical, chemical, and food and beverage industries. Orbis Biosciences was founded in 2008. Orbis Biosciences' headquarters is located in Lenexa, Kansas, USA 66214. Orbis Bios...

Frequently Asked Questions about Orbis Biosciences

  1. When was Orbis Biosciences founded?

    Orbis Biosciences was founded in 2008
  2. How much revenue does Orbis Biosciences generate?

    Orbis Biosciences generates $3.5M in revenue
  3. How much funding does Orbis Biosciences have?

    Orbis Biosciences has historically raised $1.2M in funding
  4. Where is Orbis Biosciences's headquarters?

    Orbis Biosciences's headquarters is in Lenexa Kansas, USA
  1. How many employees does Orbis Biosciences have?

    Orbis Biosciences has 16 employees
  2. What sector does Orbis Biosciences operate in?

    Orbis Biosciences is in Pharmaceuticals
  3. Who are Orbis Biosciences's competitors?

    Orbis Biosciences's top competitors are Otonomy, Amplicore, Quark Pharmaceuticals